Paper39512271
Feasibility of neoadjuvant chemotherapy for bulky early stage to stage IIIB cervical cancer in Uganda.
Namugga J and 7 others. Gynecol Oncol Rep, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Feasibility of neoadjuvant chemotherapy for bulky early stage to stage IIIB cervical cancer in Uganda. Papers, record 39512271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39512271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Feasibility of neoadjuvant chemotherapy for bulky early stage to stage IIIB cervical cancer in Uganda.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26398064 | Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries. | Am J Clin Oncol | 2016 | https://conductscience.org/library/papers/26398064 | PubMed |
| 2 | 10764435 | Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. | J Clin Oncol | 2000 | https://conductscience.org/library/papers/10764435 | PubMed |
| 3 | 37656948 | Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37656948 | PubMed |
| 4 | 11773168 | Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11773168 | PubMed |
| 5 | 38022125 | Surgical Outcomes in Early-Stage Cervical Cancer Following Radical Hysterectomy in a Resource-Limited Setting: The Experience of the National Cancer Institute (Apeksha Hospital, Maharagama), Sri Lanka. | Cureus | 2023 | https://conductscience.org/library/papers/38022125 | PubMed |
| 6 | 10202164 | Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10202164 | PubMed |
| 7 | 9345358 | Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. | Gynecol Oncol | 1997 | https://conductscience.org/library/papers/9345358 | PubMed |
| 8 | 35994243 | Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35994243 | PubMed |
| 9 | 35839811 | Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. | Lancet Glob Health | 2022 | https://conductscience.org/library/papers/35839811 | PubMed |
| 10 | 35256434 | Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. | Int J Gynecol Cancer | 2022 | https://conductscience.org/library/papers/35256434 | PubMed |
| 11 | 10334517 | Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10334517 | PubMed |
| 12 | 18929686 | Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. | J Biomed Inform | 2009 | https://conductscience.org/library/papers/18929686 | PubMed |
| 13 | 29432076 | Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29432076 | PubMed |
| 14 | 10202165 | Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10202165 | PubMed |
| 15 | 27014366 | Cervical cancer survival in a resource-limited setting-North Central Nigeria. | Infect Agent Cancer | 2016 | https://conductscience.org/library/papers/27014366 | PubMed |
| 16 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 17 | 17493669 | Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. | Gynecol Oncol | 2007 | https://conductscience.org/library/papers/17493669 | PubMed |
| 18 | 38379666 | Cervical cancer management in a low resource setting: A 10-year review in a tertiary care hospital in Kenya. | Gynecol Oncol Rep | 2024 | https://conductscience.org/library/papers/38379666 | PubMed |
| 19 | 23640393 | Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). | Br J Cancer | 2013 | https://conductscience.org/library/papers/23640393 | PubMed |
| 20 | 10202166 | Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10202166 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39512271
GET https://conductscience.org/api/papers/v1/39512271/references?page=2